Glucotrack (GCTK) Total Current Liabilities (2010 - 2025)
Glucotrack (GCTK) posted Total Current Liabilities of $4.8 million for Q4 2025, down 9.89% on a QoQ basis from $5.3 million in Q3 2025, and up 274.35% year-over-year from $1.3 million in Q4 2024.
Glucotrack (GCTK) Total Current Liabilities (2010 - 2025) Analysis & Trends
Glucotrack's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- Quarterly Total Current Liabilities rose 274.35% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 274.35% YoY) and the FY2025 annual result came in at $4.8 million, up 274.35% from the prior year.
- Total Current Liabilities was $4.8 million for Q4 2025 at Glucotrack, down from $5.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $5.3 million in Q3 2025 and bottomed at $883000.0 in Q4 2021.
- A 5-year average of $2.0 million and a median of $1.3 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities sank 37.09% — and 2025, when it soared 274.35%.
- Glucotrack's Total Current Liabilities stood at $883000.0 in 2021, then advanced by 14.72% to $1.0 million in 2022, then soared by 49.26% to $1.5 million in 2023, then dropped by 15.67% to $1.3 million in 2024, then surged by 274.35% to $4.8 million in 2025.
- Business Quant data shows GCTK's Total Current Liabilities at $4.8 million in Q4 2025, $5.3 million in Q3 2025, and $3.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | 4.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 965,000.00 |
| Jun 30, 2022 | 935,000.00 |
| Mar 31, 2022 | 916,000.00 |
| Dec 31, 2021 | 883,000.00 |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.25 Mn |